Cargando…
α-Hydroxybutyrate Is an Early Biomarker of Insulin Resistance and Glucose Intolerance in a Nondiabetic Population
BACKGROUND: Insulin resistance is a risk factor for type 2 diabetes and cardiovascular disease progression. Current diagnostic tests, such as glycemic indicators, have limitations in the early detection of insulin resistant individuals. We searched for novel biomarkers identifying these at-risk subj...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2878333/ https://www.ncbi.nlm.nih.gov/pubmed/20526369 http://dx.doi.org/10.1371/journal.pone.0010883 |
_version_ | 1782181855042207744 |
---|---|
author | Gall, Walter E. Beebe, Kirk Lawton, Kay A. Adam, Klaus-Peter Mitchell, Matthew W. Nakhle, Pamela J. Ryals, John A. Milburn, Michael V. Nannipieri, Monica Camastra, Stefania Natali, Andrea Ferrannini, Ele |
author_facet | Gall, Walter E. Beebe, Kirk Lawton, Kay A. Adam, Klaus-Peter Mitchell, Matthew W. Nakhle, Pamela J. Ryals, John A. Milburn, Michael V. Nannipieri, Monica Camastra, Stefania Natali, Andrea Ferrannini, Ele |
author_sort | Gall, Walter E. |
collection | PubMed |
description | BACKGROUND: Insulin resistance is a risk factor for type 2 diabetes and cardiovascular disease progression. Current diagnostic tests, such as glycemic indicators, have limitations in the early detection of insulin resistant individuals. We searched for novel biomarkers identifying these at-risk subjects. METHODS: Using mass spectrometry, non-targeted biochemical profiling was conducted in a cohort of 399 nondiabetic subjects representing a broad spectrum of insulin sensitivity and glucose tolerance (based on the hyperinsulinemic euglycemic clamp and oral glucose tolerance testing, respectively). RESULTS: Random forest statistical analysis selected α-hydroxybutyrate (α–HB) as the top-ranked biochemical for separating insulin resistant (lower third of the clamp-derived M(FFM) = 33 [12] µmol·min(−1)·kg(FFM) (−1), median [interquartile range], n = 140) from insulin sensitive subjects (M(FFM) = 66 [23] µmol·min(−1)·kg(FFM) (−1)) with a 76% accuracy. By targeted isotope dilution assay, plasma α–HB concentrations were reciprocally related to M(FFM); and by partition analysis, an α–HB value of 5 µg/ml was found to best separate insulin resistant from insulin sensitive subjects. α–HB also separated subjects with normal glucose tolerance from those with impaired fasting glycemia or impaired glucose tolerance independently of, and in an additive fashion to, insulin resistance. These associations were also independent of sex, age and BMI. Other metabolites from this global analysis that significantly correlated to insulin sensitivity included certain organic acid, amino acid, lysophospholipid, acylcarnitine and fatty acid species. Several metabolites are intermediates related to α-HB metabolism and biosynthesis. CONCLUSIONS: α–hydroxybutyrate is an early marker for both insulin resistance and impaired glucose regulation. The underlying biochemical mechanisms may involve increased lipid oxidation and oxidative stress. |
format | Text |
id | pubmed-2878333 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-28783332010-06-04 α-Hydroxybutyrate Is an Early Biomarker of Insulin Resistance and Glucose Intolerance in a Nondiabetic Population Gall, Walter E. Beebe, Kirk Lawton, Kay A. Adam, Klaus-Peter Mitchell, Matthew W. Nakhle, Pamela J. Ryals, John A. Milburn, Michael V. Nannipieri, Monica Camastra, Stefania Natali, Andrea Ferrannini, Ele PLoS One Research Article BACKGROUND: Insulin resistance is a risk factor for type 2 diabetes and cardiovascular disease progression. Current diagnostic tests, such as glycemic indicators, have limitations in the early detection of insulin resistant individuals. We searched for novel biomarkers identifying these at-risk subjects. METHODS: Using mass spectrometry, non-targeted biochemical profiling was conducted in a cohort of 399 nondiabetic subjects representing a broad spectrum of insulin sensitivity and glucose tolerance (based on the hyperinsulinemic euglycemic clamp and oral glucose tolerance testing, respectively). RESULTS: Random forest statistical analysis selected α-hydroxybutyrate (α–HB) as the top-ranked biochemical for separating insulin resistant (lower third of the clamp-derived M(FFM) = 33 [12] µmol·min(−1)·kg(FFM) (−1), median [interquartile range], n = 140) from insulin sensitive subjects (M(FFM) = 66 [23] µmol·min(−1)·kg(FFM) (−1)) with a 76% accuracy. By targeted isotope dilution assay, plasma α–HB concentrations were reciprocally related to M(FFM); and by partition analysis, an α–HB value of 5 µg/ml was found to best separate insulin resistant from insulin sensitive subjects. α–HB also separated subjects with normal glucose tolerance from those with impaired fasting glycemia or impaired glucose tolerance independently of, and in an additive fashion to, insulin resistance. These associations were also independent of sex, age and BMI. Other metabolites from this global analysis that significantly correlated to insulin sensitivity included certain organic acid, amino acid, lysophospholipid, acylcarnitine and fatty acid species. Several metabolites are intermediates related to α-HB metabolism and biosynthesis. CONCLUSIONS: α–hydroxybutyrate is an early marker for both insulin resistance and impaired glucose regulation. The underlying biochemical mechanisms may involve increased lipid oxidation and oxidative stress. Public Library of Science 2010-05-28 /pmc/articles/PMC2878333/ /pubmed/20526369 http://dx.doi.org/10.1371/journal.pone.0010883 Text en Gall et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Gall, Walter E. Beebe, Kirk Lawton, Kay A. Adam, Klaus-Peter Mitchell, Matthew W. Nakhle, Pamela J. Ryals, John A. Milburn, Michael V. Nannipieri, Monica Camastra, Stefania Natali, Andrea Ferrannini, Ele α-Hydroxybutyrate Is an Early Biomarker of Insulin Resistance and Glucose Intolerance in a Nondiabetic Population |
title | α-Hydroxybutyrate Is an Early Biomarker of Insulin Resistance and Glucose Intolerance in a Nondiabetic Population |
title_full | α-Hydroxybutyrate Is an Early Biomarker of Insulin Resistance and Glucose Intolerance in a Nondiabetic Population |
title_fullStr | α-Hydroxybutyrate Is an Early Biomarker of Insulin Resistance and Glucose Intolerance in a Nondiabetic Population |
title_full_unstemmed | α-Hydroxybutyrate Is an Early Biomarker of Insulin Resistance and Glucose Intolerance in a Nondiabetic Population |
title_short | α-Hydroxybutyrate Is an Early Biomarker of Insulin Resistance and Glucose Intolerance in a Nondiabetic Population |
title_sort | α-hydroxybutyrate is an early biomarker of insulin resistance and glucose intolerance in a nondiabetic population |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2878333/ https://www.ncbi.nlm.nih.gov/pubmed/20526369 http://dx.doi.org/10.1371/journal.pone.0010883 |
work_keys_str_mv | AT gallwaltere ahydroxybutyrateisanearlybiomarkerofinsulinresistanceandglucoseintoleranceinanondiabeticpopulation AT beebekirk ahydroxybutyrateisanearlybiomarkerofinsulinresistanceandglucoseintoleranceinanondiabeticpopulation AT lawtonkaya ahydroxybutyrateisanearlybiomarkerofinsulinresistanceandglucoseintoleranceinanondiabeticpopulation AT adamklauspeter ahydroxybutyrateisanearlybiomarkerofinsulinresistanceandglucoseintoleranceinanondiabeticpopulation AT mitchellmattheww ahydroxybutyrateisanearlybiomarkerofinsulinresistanceandglucoseintoleranceinanondiabeticpopulation AT nakhlepamelaj ahydroxybutyrateisanearlybiomarkerofinsulinresistanceandglucoseintoleranceinanondiabeticpopulation AT ryalsjohna ahydroxybutyrateisanearlybiomarkerofinsulinresistanceandglucoseintoleranceinanondiabeticpopulation AT milburnmichaelv ahydroxybutyrateisanearlybiomarkerofinsulinresistanceandglucoseintoleranceinanondiabeticpopulation AT nannipierimonica ahydroxybutyrateisanearlybiomarkerofinsulinresistanceandglucoseintoleranceinanondiabeticpopulation AT camastrastefania ahydroxybutyrateisanearlybiomarkerofinsulinresistanceandglucoseintoleranceinanondiabeticpopulation AT nataliandrea ahydroxybutyrateisanearlybiomarkerofinsulinresistanceandglucoseintoleranceinanondiabeticpopulation AT ferranniniele ahydroxybutyrateisanearlybiomarkerofinsulinresistanceandglucoseintoleranceinanondiabeticpopulation AT ahydroxybutyrateisanearlybiomarkerofinsulinresistanceandglucoseintoleranceinanondiabeticpopulation |